CME INDIA DISCUSSION . Medico-legal Implications of Prescribing Wegovy and Mounjaro in India.🗓️ Date: 5th July 2025.📍 Topic initiated by Dr Ashish. 💬 Discussion Highlights. 🔹 Dr Ashish raised a crucial medico-legal query regarding the prescription of Wegovy or Mounjaro for.

C3 Glomerulopathy & Idiopathic MPGN: Clinical-Histologic Predictors of Renal Outcomes. 🧾 CJASN, June 2025 | DOI: 10.2215/CJN.0000000751.👨‍⚕️ Ghaddar M, Caravaca-Fontán F, Praga M, et al. 🔍 Background. C3 glomerulopathy (C3G) and idiopathic immune complex MPGN (IC-MPGN) are rare

SGLT2 Inhibitors in Cancer Patients with Diabetes: A Game-Changer in Cardio-Oncology?. 🧬 Background. Type 2 Diabetes Mellitus (T2DM) increases both cardiovascular risk and cancer risk. Cancer therapies (especially anthracyclines) add cardiotoxicity, leading to increased

🧬 Gene Therapy & Genome Editing in Lipoprotein Disorders – Clinical Pearls. 🧠 The Genetic Basis. Lipoprotein disorders are often driven by genetic mutations—both monogenic (like familial hypercholesterolemia, FCS) and polygenic (common hyperlipidaemia). These genetic

Burnout Among Indian Healthcare Practitioners (HCPs).Dr Anuj Maheshwari et al. @AnujMah51145112.🔹 Burnout is Real and Rampant.Nearly 1 in 4 Indian HCPs experiences all three domains of burnout – personal, work-related, and patient-related. 🔹 Personal Burnout Most Prevalent.🧠

Differential Effect of GLP-1 Receptor Agonists and SGLT2 Inhibitors on Lower-Extremity Amputation Outcomes in Type 2 Diabetes.Published in Diabetes Care – June 25, 2025. 👨‍⚕️ Lead Authors: Alexander T. Hong, Ivan Y. Luu et al. 📊 Study Type: Retrospective cohort using TriNetX EHR

The MONO Phenotype in India’s Metabolic Landscape.@drmohanv @TheLancetEndo.@IntDiabetesFed @banshisaboo.@atherosociety @EndoConnect.@AskDrShashank.🔬 1. Metabolically Obese Non-Obese (MONO) is highly prevalent. Prevalence: 43.3% of Indian adults fall into the MONO category

🧾 CME INDIA – Case Note. "Hypertension, Hypokalemia, and the Hidden Culprit – Unmasking Primary Aldosteronism". 👩‍⚕️ Clinical Vignette. 🔹 Patient: 42-year-old woman.🔹 Symptoms: Headache, palpitations, fatigue.🔹 Vitals: BP 174/112 mmHg.🔹 Medications: On 3 antihypertensives +.

Tri-Gunas in Medicine: A Spiritual Framework for Education, Empathy, and Ethics. 🔗 JAPI, Vol 73, Issue 7, July 2025.👨‍⚕️ Authors: Shambo Samrat Samajdar, Jyotirmoy Pal, Nandini Chatterjee, Mrinal K Roy,Dr Shashank Joshi .🔗 Download PDF. 🔹 Why This Article Matters to Clinicians.

Clinical Pearls based on the landmark NEJM study:.“Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women” (PURPOSE 1 Trial). 🧠 Key Clinical Pearls. Game-Changer in HIV PrEP:.Twice-yearly subcutaneous lenacapavir resulted in zero HIV infections among 2134

🧘‍♂️ Yoga in Type-2 Diabetes: A 24-Week Randomized Controlled Study.@AskDrShashank @Yoga_Journal.@exercise .(Hospital-based study | 104 participants | PMC10424277). 🔹 Background and Aim. Cardiovascular risk in type-2 diabetes mellitus (T2DM) is driven by persistent hyperglycemia,

So. Hyperkalemia is said to be the "Syphilis" for ECG changes: The great Masquerader.

Dr DP Khaitan Gaya: . Very interesting case. Hyperkalemia may mimic at times with Brugada syndrome,as in ths ECG. Dr Satish Kumar . That's the reason Hyperkalemia is said to be the "Syphilis" for ECG changes: *The great Masquerader.*. Dr Sk Goenka, Begusarai: . Wonderful word

RBS - "HI" (which she was not able to comprehend), . Serum K 10+,. Severe Metabolic Acidosis,. Post admission, the ECG monitor almost started showing the Sine Wave pattern and the patient started gasping . We did all the pharmacological measures for combating hyperkalemia

Case by Dr Satish Kumar , Cardiologist, Wellmark Hospital,Bokaro: .@EcgsOnly @smithECGBlog @ECG_BUDDY_ARPI @EcgOxford. 49M, known patient of Post-Pancreatitis DM (PPDM or DM Type - 3c), admitted with respiratory distress, recurrent vomiting followed by becoming unresponsive for

Dr Bhadresh Zaveri: . Any role of Aspirin in primary prevention of CV risk in high LPa level?. CME INDIA . Aspirin is not routinely recommended for primary prevention of cardiovascular disease, even in individuals with elevated lipoprotein(a) [Lp(a)] levels, due to the risk of.